Anti-AgingLongevitySubcutaneous

Cartalax

Typical Dose

0.1–0.5 mg

Frequency

Daily

Half-Life

~2-4 hours

Research-use dosing; specific study population not established.

Cartalax Overview

Mechanism of Action

Cartalax is a short bioregulator peptide that modulates cartilage and connective tissue metabolism, potentially supporting joint health and repair.

Half-Life

~2-4 hours

Timing

Morning

Common Stacks

  • BPC-157
  • TB-500

Cartalax Dosing Protocol

Standard

100-500 mcg/day

Cartalax Expected Timeline

No timeline data available.

Cartalax Side Effects

Mild injection site irritation

Cartalax Research Studies

No studies referenced.

Cartalax FAQ

What is Cartalax?

A bioregulator peptide studied for cartilage and joint support.

Related Protocols